By the Street Scout Staff

1. Centerview Partners
Founded 2006 by Blair Effron and Robert Pruzan. Healthcare practice launched 2009 from Merrill Lynch team. Advisory-only; dominates large-cap biopharma sell-sides.
Senior banker: E. Eric Tokat, Co-President of Investment Banking and founder of the healthcare practice; 100+ deals, $500B+ value.
Little public research or institutional sales (pure advisory).

2. Leerink Partners
Founded 1995 by Jeffrey Leerink as a healthcare-only firm. Survived SVB collapse via 2023 employee/Baupost buyout; independent again. Leader in biopharma ECM; growing M&A.
Senior bankers: Jeffrey Leerink (CEO); Tom Davidson (Co-President, Co-Head Global IB, joined 2024 from PJT); Dan Dubin (Vice Chairman).
Strong research and healthcare institutional sales supporting ECM. Notable research names include Faisal Khurshid and Mike Kratky.

3. Evercore
Founded 1995 by Roger Altman. Public independent advisor with growing equities (Evercore ISI). Strong healthcare M&A plus some ECM.
Senior bankers: François Maisonrouge (Chairman, Global Healthcare); Joe Modisett (SMD, ex-Morgan Stanley HC head); recent hires include Ben Carpenter and Eric Rabinowitz.
Evercore ISI research ranks at the top of Extel/II surveys. Umer Raffat is a perennial #1 in large-cap biotech and specialty pharma.
Has institutional sales via its equities platform.

4. Lazard
Founded 1848. Oldest name on the list; global independent advisor with long healthcare franchise.
Senior bankers: David Gluckman (Vice Chairman of IB, Global Head of Healthcare); Stephen Sands (Global Chairman of Healthcare). Recent adds include Geoffrey Porges and services specialists John Koski and Robert Lowe.
Limited dedicated research/sales versus full-service peers.

5. Moelis & Company
Founded 2007 by Ken Moelis (ex-UBS). Strong in healthcare services, HCIT, and sponsor work; expanding life sciences.
Senior bankers: Rich Harding (Head of Healthcare Services); Jaime Burnes (MD, biotech/life sciences, San Francisco); Lillian Tsinikas (HCIT). Ken Moelis is now Executive Chairman; Navid Mahmoodzadegan is CEO.
Primarily advisory; modest research and sales footprint.

Elite boutiques win on senior attention and independence. Leerink and Evercore add research/sales muscle that Centerview, Lazard, and Moelis generally lack. Rankings shift by sub-sector (biopharma M&A vs. services vs. ECM).